Table 2.

Characteristics of tumors

Case	Histopathology	Primary		Metastases					Previous Treatment
		Location	Size	Liver	Pancreas	Bowel	Lymph Nodes	Other
		1	duct cell carcinoma sclerosing cholangitis	common duct	diffuse	minor	no	no	0/9	no	none
2	spindle cell sarcoma	duodenum	5 cm	extensive	no	no	0/38	no	none
3	duct cell carcinoma sclerosing cholangitis	hilum	9.5 cm	extensive	no	no	12/50	lungs*	none
4	spindle cell sarcoma	duodenum (4th)	8 cm	extensive	no	no	0/57	no	none
5	carcinoid	duodenum (2nd)	1.8 cm	extensive	no	no	5/35	no	adriamycin and tumor embolization
6	carcinoid	stomach	3 cm	extensive	no	no	2/27	no	open liver biopsy
7	recurrent duct cell	intrahepatic	11 cm	extensive	no	extensive	0/28	no	resection of klatskin tumor hepatico-jejunostomy on 3/26/86 followed by 4500 RADS
8	duct cell carcinoma	liver hilum	7.5 cm	regional	no	no	0/94	no	exploratory laparotomy
9	duct cell carcinoma	common duct	10 cm	extensive	head and body	no	6/30	portal vein, skull*	none
10	duct cell carcinoma	liver hilum	11.5 cm	direct invasion	0	0	0/70	no	percutaneous transhepatic stent
11	cholangiocarcinoma	liver	14 cm	extensive	head	no	0/28	no	none
12	duct cell carcinoma sclerosing cholangitis	common duct	6 cm	extensive	no	no	2/21	positive margin at the hepatic vein	total colectomy and ileostomy
13	recurrent cholangiocarcinoma	liver	multiple lesions up to 5 cm	extensive	no	no	0/34	no	left triseg-mentectomy 8 months previously
14	hepatocellular carcinoma, PNCB**	liver	11 cm	extensive	no	no	0/25	portal vein invasion	exploratory laparotomy
15	carcinoid	pancreas	4.5 cm	extensive	–	stomach colon	0/38	no	open liver biopsy

^**PNCB = Hepatitis B postnecrotic cirrhosis;

^*Diagnosed postoperatively upon retrospective review of X-ray films.